News

22/10/2021

Zdravlje Announces Partnership with Celltrion Healthcare for Monoclonal Antibody COVID-19 Treatment

Zdravlje announces signing of agreement with Celltrion Healthcare, a leading global biopharmaceutical company, for regional product rights to regdanvimab (CT-P59), a monoclonal antibody treatment for COVID-19 Regdanvimab (CT-P59) significantly reduced the risk of COVID-19 related hospitalisation or death by 72% for patients at high-risk of progressing to severe COVID-19 and […]
01/11/2021

Dragana Mirkovic, Product Manager, a new member of the Commercial Division in Zdravlje AD

Zdravlje is pleased to announce that as of 1st November 2021, Dragana Mirkovic has joined our team as a Product Manager. Dragana will report directly to Dragan Cirkovic, Commercial Director. Dragana graduated as a Doctor of Medicine from the University in Belgrade, specialising in Paediatrics. She brings valuable experience gained […]
20/12/2021

Zdravlje continues with “Cap for Handicap”

    Zdravlje Leskovac continues its several-years’ activity aimed to support persons with disabilities as a partner to the “Cap for Handicap” Association. During the previous years since the beginning of this socially responsible activity, the caps that were collected with great dedication by employees of Zdravlje and its partners […]
10/01/2022

Semir Attar joins Zdravlje Leskovac as Director of Regulatory & Public Affairs

Zdravlje is pleased to announce that as of 1 January 2022, Mr. Semir Attar has joined our senior management team as Director of Regulatory & Public Affairs, directly reporting to Kiren Naidoo (CEO). Semir brings over 20 years of valuable pharmaceutical industry experience across Regulatory, Public Affairs, Market Access and […]
17/01/2022

Expansion of Zdravlje’s Commercial Capabilities

Zdravlje is pleased to announce an important expansion of our commercial capabilities in Serbia. As of 10 January, Zdravlje has added five medical representatives who will be working directly with doctors and pharmacists to provide professional support, expertise and information on our high quality product portfolio. Our medical representatives will […]
28/02/2022

Rare Disease World Day – 28 February

On the occasion of the Rare Disease World Day, 28 February, Zdravlje is sharing the general public information to help raise the awareness and generate the change for the 300 million people worldwide living with a rare disease, their families and carers.   What is a rare disease? A disease […]
07/03/2022

Tamara Vasojevic joins Zdravlje Leskovac as Group Human Resources Director

Zdravlje is pleased to announce that as of 7 March 2022, Ms. Tamara Vasojevic has joined our senior management team as Group Human Resources Director, directly reporting to Kiren Naidoo (CEO). Tamara graduated from the Faculty of Philosophy in Belgrade, majoring in Adult Education, with additional education and development in […]
08/03/2022

Radmila Jakovljevic, Supply and Business Development Manager, onboarding the Commercial Division in Zdravlje AD

Zdravlje is pleased to announce that as of 7 March 2022, Radmila Jakovljevic has joined our team as a Supply and Business Development Manager. Radmila will report directly to Dragan Cirkovic, Commercial Director. Radmila graduated from the Faculty of Agriculture at the University in Belgrade, and has a Master degree […]
17/03/2022

Zdravlje A.D. Signs License Agreement with Medicines Patent Pool for nirmatrelvir

Belgrade, Serbia 17 March 2022 –– Zdravlje A.D. (Zdravlje) announces the signing of a license agreement with the Medicines Patent Pool (MPP) for a generic version of nirmatrelvir, the novel oral COVID-19 antiviral medicine (PF-07321332) developed by Pfizer, which is administered in combination with low dose ritonavir (PF-07321332; ritonavir). This […]